Survival

SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in TG Therapeutics, Inc. of Class Action Lawsuit and Upcoming Deadline – TGTX

Retrieved on: 
Wednesday, August 17, 2022 - 5:54pm

To discuss this action, contact Robert S. Willoughby at newaction@pomlaw.com or 888.476.6529 (or 888.4-POMLAW), toll-free, Ext.

Key Points: 
  • To discuss this action, contact Robert S. Willoughby at newaction@pomlaw.com or 888.476.6529 (or 888.4-POMLAW), toll-free, Ext.
  • Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased.
  • TG Therapeutics, a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases.
  • Founded by the late Abraham L. Pomerantz, known as the dean of the class action bar, Pomerantz pioneered the field of securities class actions.

Global Protein Labeling Market Report to 2028 - Featuring Thermo Fisher Scientific, Merck and PerkinElmer Among Others - ResearchAndMarkets.com

Retrieved on: 
Wednesday, August 17, 2022 - 5:10pm

The "Global Protein Labeling Market Size, Share & Industry Trends Analysis Report By Method, By Product, By Application, By Regional Outlook and Forecast, 2022-2028" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Global Protein Labeling Market Size, Share & Industry Trends Analysis Report By Method, By Product, By Application, By Regional Outlook and Forecast, 2022-2028" report has been added to ResearchAndMarkets.com's offering.
  • The Global Protein Labeling Market size is expected to reach $3.2 billion by 2028, rising at a market growth of 7.5% CAGR during the forecast period.
  • As a result, proteomics and protein chemistry is being used to investigate the protein binding mechanism.
  • Covalent protein labeling makes imaging mammalian proteins in living cells easier and more versatile, as well as allowing for protein capture in vitro.

Zendure Addresses Energy Insecurity with Semi-Solid State Battery Technology

Retrieved on: 
Wednesday, August 17, 2022 - 3:55pm

PALO ALTO, Calif., Aug. 17, 2022 /PRNewswire/ -- Zendure, one of the fastest growing start-ups in the energy tech sector, is on a mission to ensure everyone has access to reliable, affordable energy, and they've brought a new weapon ally into the fight: semi-solid state battery technology.

Key Points: 
  • PALO ALTO, Calif., Aug. 17, 2022 /PRNewswire/ -- Zendure, one of the fastest growing start-ups in the energy tech sector, is on a mission to ensure everyone has access to reliable, affordable energy, and they've brought a new weapon ally into the fight: semi-solid state battery technology.
  • Semi-solid state batteries boast a higher energy density and greater damage resistance than lithium-ion phosphate (LiFePO4) batteries, providing homes and businesses with more energy storage and enhanced product safety.
  • "Recent natural disasters, grid failures, and the rising cost of energy are becoming a critical concern for communities around the world.
  • Zendure is offering a solution that delivers energy security and long-term cost savings," said Bryan Liu, CEO & Founder of Zendure.

Valley Food Storage's New Emergency Preparedness 'Bug Out Bag' Ticks the Five C's of Survival

Retrieved on: 
Wednesday, August 17, 2022 - 1:44pm

Valley Food Storage offers storage-ready packaged food items that are made from clean and simple ingredients, and free from additives and fillers.

Key Points: 
  • Valley Food Storage offers storage-ready packaged food items that are made from clean and simple ingredients, and free from additives and fillers.
  • Valley Food Storage's new 15-piece emergency food, water, and shelter survival kit is on sale for 25% off for a limited time.
  • "Valley Food Storage is committed to delivering the best quality emergency preparedness kits available, for families who want to actively prepare for emergencies without compromising on food safety or quality," saidPaul Jones, Director of Product Development, Valley Food Storage.
  • That's why our newest emergency preparedness kit checks the five C's of survival Cutting, Combustion, Contain, Cover, and Cordage," saidJones.

Enlivex Receives Israeli Ministry of Health Approval for the Initiation of a Phase I/II Trial Evaluating Allocetra™ Alone and in Combination with a PD1 Checkpoint Inhibitor in Patients with Advanced Solid Tumors

Retrieved on: 
Wednesday, August 17, 2022 - 1:00pm

We aim to build on these results in our upcoming Phase I/II trial and are pleased that the Israeli Ministry of Health has cleared it for initiation.

Key Points: 
  • We aim to build on these results in our upcoming Phase I/II trial and are pleased that the Israeli Ministry of Health has cleared it for initiation.
  • The planned Phase I/II trial is a multicenter, open-label, dose escalation trial that is expected to enroll up to 48 patients with advanced solid tumors across two trial stages.
  • Stage 2 will evaluate escalating doses of Allocetra administered IV or IP and combined with anti-PD1 therapy.
  • Patients in Stage 2 will receive three injections of Allocetra concomitantly with the studied anti-PD1 agent.

DGAP-News: Defence Therapeutics Inc.:  BREAKTHROUGH DISCOVERY: DEFENCE’S ACCUMTM VARIANT 'A1' CONVERTS MESENCHYMAL STROMAL CELLS INTO POTENT ANTIGEN PRESENTING CELLS SUITABLE FOR CANCER VACCINATION

Retrieved on: 
Wednesday, August 17, 2022 - 7:02am

With respect to cancer, the immune system relies on dendritic cells (DCs), a subset of potent endogenous APCs, to prime cytotoxic T lymphocytes (CTLs).

Key Points: 
  • With respect to cancer, the immune system relies on dendritic cells (DCs), a subset of potent endogenous APCs, to prime cytotoxic T lymphocytes (CTLs).
  • Unfortunately, however, most cancer cells can acquire strategies to escape DC-elicited immunity resulting in the development of deadly tumors.
  • To overcome this issue, Defence Therapeutics applied a novel strategy, which consists at reprogramming the immune-suppressive MSCs to convert them into potent APCs.
  • This application discovered that it uses a unique cell type to which tumor cells are not programmed to respond.

SeaWorld Partners with Wildlife Authorities and Conservation Groups to Help 10 Endangered and Non-Releasable Kemp's Ridley Sea Turtles

Retrieved on: 
Tuesday, August 16, 2022 - 7:11pm

Fish and Wildlife Service (USFWS), National Oceanic and Atmospheric Administration (NOAA) Fisheries, and the conservation groups Cayman Turtle Centre and Turtles Fly Too, to help ten endangered Kemp's Ridley sea turtles as part of an international conservation effort.

Key Points: 
  • Fish and Wildlife Service (USFWS), National Oceanic and Atmospheric Administration (NOAA) Fisheries, and the conservation groups Cayman Turtle Centre and Turtles Fly Too, to help ten endangered Kemp's Ridley sea turtles as part of an international conservation effort.
  • Fortunately, the Kemp's Ridley sea turtle population began growing as international conservation efforts to reduce their main threats were set in place.
  • As the wild population increased, the project was concluded, and these turtles are the last remaining of this group.
  • SeaWorld Entertainment, Inc. owns or licenses a portfolio of recognized brands including SeaWorld, Busch Gardens, Aquatica, Sesame Place and Sea Rescue.

DGAP-News: Is BioLife Sciences (OTCPK: BLFE) An OTC Company Primed For Growth?

Retrieved on: 
Tuesday, August 16, 2022 - 7:05pm

Is BioLife Sciences (OTCPK: BLFE) An OTC Company Primed For Growth?

Key Points: 
  • Is BioLife Sciences (OTCPK: BLFE) An OTC Company Primed For Growth?
  • BioLife Sciences Inc. (BioLife), a commercialization accelerator, licensor and developer of technologies, has reportedly provided investors with a significant company update throughout the course of a two-year transformation.
  • Lets take a look at some of what the company has been up to over the last two years.
  • In February of 2022, BioLife completed the acquisition of Health Box LLC an Arizona-based orthomolecular medicine and natural health products company.

LUNGevity Launches New Small Cell Lung Cancer Patient Gateway

Retrieved on: 
Tuesday, August 16, 2022 - 6:37pm

WASHINGTON, Aug. 16, 2022 /PRNewswire/ -- LUNGevity Foundation, the nation's leading lung cancer-focused nonprofit organization, has launched the Small Cell Lung Cancer Patient Gateway. This new resource completes the suite of six Patient Gateways, where lung cancer survivors can access relevant information tailored to their specific subtype. Small cell lung cancer accounts for 15% of all lung cancers and is often diagnosed in people with a history of smoking. The Gateway allows survivors to locate specialists and resources more easily. The Patient Gateway also features information on treatment options and the ability to connect with a community of fellow survivors and their caregivers.

Key Points: 
  • The specialized resource offers patients with small cell lung cancer (SCLC) and their caregivers access to treatment information, informative webinars, the latest scientific news, and a supportive community
    WASHINGTON, Aug. 16, 2022 /PRNewswire/ -- LUNGevity Foundation, the nation's leading lung cancer-focused nonprofit organization, has launched the Small Cell Lung Cancer Patient Gateway .
  • The Small Cell Lung Cancer Patient Gateway is a user-friendly and easily accessible information portal that offers the latest medical updates and practical resources for patients and their caregivers.
  • The Small Cell Lung Cancer Patient Gateway joins the EGFR, KRAS, ALK, Rare Mutations and Fusions, and Non-Small Cell Lung Cancer (NSCLC) platforms at gateway.lungevity.org .
  • The Small Cell Lung Cancer Patient Gateway is supported by generous sponsorships from AstraZeneca, EMD Serono, Genentech, and Jazz Pharmaceuticals.

British Swim School Celebrates Inclusion on Prestigious INC 5000 List

Retrieved on: 
Tuesday, August 16, 2022 - 6:00pm

VIRGINIA BEACH, Fla., Aug. 16, 2022 /PRNewswire-PRWeb/ -- British Swim School, the nation's leading "learn to swim" franchise is thrilled to announce one of its highest rankings ever on the Inc. 5000. The company is ranked #737 on the newly released Inc 5000, the most prestigious compilation of the nation's fastest-growing private companies. The list represents a unique look at the most successful companies within the American economy's most dynamic segment — its independent small and midsized businesses.

Key Points: 
  • VIRGINIA BEACH, Fla., Aug. 16, 2022 /PRNewswire-PRWeb/ -- British Swim School , the nation's leading "learn to swim" franchise is thrilled to announce one of its highest rankings ever on the Inc. 5000.
  • Coming off their strongest year ever in 2021, British Swim School is continuing their booming US and Canadian expansion in 2022.
  • This momentum demonstrates an ever-growing need for swim lessons, with British Swim School primed to be the premier swim lesson provider in these communities.
  • Part of the Buzz Franchise Brands family, British Swim School currently operates over 250 schools across the United States and Canada.